Palliative radiation therapy for head and neck cancer: Toward an optimal fractionation scheme
β Scribed by Allen M. Chen; Andrew Vaughan; Samir Narayan; Srinivasan Vijayakumar
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 86 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background.
To analyze the efficacy of various fractionation schedules for the palliation of head and neck cancer with radiation therapy.
Methods.
Sixty patients completed palliative irradiation to primary head and neck sites. The most commonly used fractionation regimen was the one previously described by the Radiation Therapy Oncology Group (RTOG) protocol 85β02 and was designed to deliver 440 cGy using 370 cGy fractionation, administered twice a day for 2 consecutive days at 2β to 3βweek intervals for 3 total cycles.
Results.
The rates of palliative response were 83%, 77%, 67%, 86%, and 60% among those treated using the RTOG regimen, 7000 cGy/35 fractions, 3000 cGy/10 fractions, 3750 cGy/15 fractions, and 2000 cGy/5 fractions, respectively (p = .42). Nine percent (2/23) of those treated with the RTOG regimen developed grade 3+ toxicity compared with 37% among those treated with other schedules (p = .01).
Conclusion.
Although all of the analyzed schedules were effective at providing palliation, the RTOG 85β02 regimen was associated with less toxicity. Β© 2008 Wiley Periodicals, Inc. Head Neck, 2008
π SIMILAR VOLUMES
## Abstract Due to the close spatial relationship of head and neck and skull base tumors to numerous normal anatomical structures, conventional photon radiation therapy can be associated with significant acute and longβterm treatmentβrelated toxicities. Superior dose localization properties of prot
## Abstract ## Background. The aim of this study was to determine the incidence of esophageal toxicity after radiation therapy for head and neck cancer. ## Methods. The records of 211 patients treated by radiation therapy for head and neck cancer were reviewed to identify those with dysphagia la